Clinical Study
Efficacy of Tumor-Infiltrating Lymphocytes Combined with IFN-α in Chinese Resected Stage III Malignant Melanoma
Table 3
Univariate analysis.
| | DFS (months) | | mOS (months) | |
| Age (years) | | >60 | 25.69 | 0.637 | 42.79 | 0.814 | ≤60 | 21.27 | 38.82 | Sex | | Male | 20.47 | 0.560 | 37.33 | 0.861 | Female | 28.17 | 44.10 | KPS scores | | ≥80 | 26.69 | 0.032 | 49.33 | 0.020 | <80 | 13.27 | 21.50 | Cell numbers for transfusion | | <8 × 109 | 6.91 | 0.000 | 16.94 | 0.000 | ≥8 × 109 | 30.97 | 53.46 | Culture days | | <30 | 30.77 | 0.014 | 55.78 | 0.001 | ≥30 | 13.79 | 24.43 | R-CIK | Yes | 29.22 | 0.578 | 44.29 | 0.791 | No | 22.35 | 35.28 |
|
|